Skip to content
Our Approach
Pipeline
Our Team
News
Contact Us
X
Contact
News
Latest Press Releases
View More
February 2, 2026
Mwyngil Therapeutics Announces Updates on NLRP3 Portfolio
November 6, 2025
Mwyngil Therapeutics Announces In-Licensing of GPR75 Modulators and Cell-Surface Discovery Platform from Expert Systems Inc.
Latest Publications
View More
February 2, 2026
Mwyngil Therapeutics Announces Updates on NLRP3 Portfolio
November 6, 2025
Mwyngil Therapeutics Announces In-Licensing of GPR75 Modulators and Cell-Surface Discovery Platform from Expert Systems Inc.
